glp-1 sex drive Clinical review of how glucagon-like peptide-1 agonist obesity medications decrease sexual desire, and a biopsychosocial model for why we don't 'see' it GLP-1 meds can tank your

Endoscopy & GLP-1 Receptor Agonists Oct 28, 2024 The new wave of aspiration risk is here

Interestingly, clinical data from the SURMOUNT trials showed that mood improvement was dose-dependent, meaning higher doses were associated with better mood scores overall

On busy days (or every day!), swap any meal with Build Your Meal Plan options

The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease

Patient assistance programs for eligible patients If your household income falls below certain thresholds, you may qualify for free medication through a Patient Assistance Program (PAP)

Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial